BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

NXT-Dx Launches Its Multiplexed Immunoassay Service


10/24/2013 10:05:01 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

October 24, 2013 -- NXT-Dx expands its service portfolio with a unique multiplexed immunoassay service, allowing parallel testing of 96 protein markers in 92 samples. The initial assay focuses on cancer markers but additional assays for inflammation and cardiovascular diseases are expected to follow soon. For little over 2 years, NXT-Dx has been providing state-of-the-art research testing services in epigenetics and transcriptomics to its global customers, from its headquarters in Ghent, Belgium. Now the company is expanding its service portfolio with the addition of its multiplexed immunoassay service.

“NXT-Dx has been helping researchers in epigenetics and transcriptomics for the past 2 years to achieve their research goals, by offering excellent services combined with great follow-up and support. Now we want extend our portfolio by offering our multiplexed immunoassay service to existing and new customers.”. (Maarten Braspenning: Operational and commercial director).

The multiplexed immunoassay allows to quantify 96 protein markers in 92 samples in parallel with no trade-off in data quality, at affordable cost and with minimal input material (as low as 1µL from plasma, serum, fine needle biopsy, tissue lysate, cell lysate, micro-dialysis fluid and synovial fluid).

For additional information contact:

Maarten Braspenning

NXT-Dx

+32 9 265 02 52

maarten.braspenning@nxt-dx.com

www.nxt-dx.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES